Moderna

We only need a few more clicks to be able to show the most read stories for this topic. Take a look at the latest headlines below and help us out by clicking on what you find interesting!

Yesterday

Hantavirus Has Low Pandemic Risk But Moderna Stays Vigilant Scrip Pharma Intelligence16:30 20-May-26

Moderna Museet director Gitte Ørskou to leave on August 31 this year Sweden Herald11:50 20-May-26

Old Moderna research triggers false hantavirus claims online AFP Fact Check03:55 20-May-26

In the last 7 days

Pfizer, Moderna COVID vaccines 70% to 76% effective against severe illness in kids in 2022, data suggest Center for Infectious Disease Research and Policy19:27 19-May-26

Moderna mRNA flu vaccine more effective than standard shot Skeptical Raptor19:45 18-May-26

How a dated Prague flat became a chic urban home Expats CZ07:06 18-May-26

Assessing Moderna (MRNA) Valuation After Flu Vaccine Data And Hantavirus Program Interest Simply Wall St11:04 16-May-26

Much Ado About “About” JD Supra15:28 15-May-26

Moderna Museet and Kunsthaus Zürich present House of Nisaba ArtDaily00:38 14-May-26

In the last month

Moderna’s AI Could Get a Hantavirus Vaccine Here Faster PYMNTS.com18:28 12-May-26

Moderna's Revenues See Strong International Momentum in Q1 Earnings Zacks15:05 12-May-26

Hantavirus Trade Stalls as Officials Say Risk to Public Ranges from “Low” to “Very, Very Low” Power Corridor05:08 12-May-26

Moderna Stock Is Surging on Hantavirus Threats. Its Chart Offers a Harsh Dose of Reality. Barchart20:49 11-May-26

Moderna Says It's Researching a Hantavirus Vaccine. The Drugmaker's Stock Is Surging. Investopedia19:10 11-May-26

A New Hantavirus Vaccine Is in the Works WIRED18:21 11-May-26

Moderna stock surges 22% in 2 days as investors monitor hantavirus outbreak Business Insider16:54 11-May-26

Biotech Stocks Rally on Hantavirus Fears: Is the Surge Overdone? The Motley Fool16:53 11-May-26

Moderna shares extend gains as hantavirus vaccine work draws attention Proactive Investors (US)16:53 11-May-26

Hantavirus Scare Sparks Vaccine Stock Rally: Moderna, Novavax Climb Benzinga14:32 11-May-26

Moderna Shares Surge On Hantavirus Concerns: What Investors Need To Know Benzinga14:12 11-May-26

Investors really want Moderna to whip up a hantavirus vaccine Sherwood11:10 11-May-26

Stock Market Today: S&P 500, Dow Futures Fall As Trump Rejects 'Totally Unacceptable' Iran Peace Proposal—Micron… Benzinga10:48 11-May-26

Moderna (MRNA) Shares Skyrocket, What You Need To Know Barchart21:27 8-May-26

MRNA Stock Alert: Moderna Surges on Hantavirus Vaccine Hopes Barchart21:07 8-May-26

Moderna flags work on hantavirus vaccines before cruise outbreak Boston Globe18:53 8-May-26

Moderna Stock Rises On Positive Phase 3 Flu Data: What Investors Need To Know Benzinga14:35 8-May-26

Moderna’s mRNA flu vaccine more effective than current SOC Clinical Trials Arena10:20 8-May-26

Moderna, Vir among early 2026 top infectious disease gainers BioWorld21:50 7-May-26

Phase 3 trial finds Moderna mRNA flu vaccine outperforms standard vaccine in older adults Center for Infectious Disease Research and Policy18:28 7-May-26

Moderna Stock Gives Back Early Gains: What's Happening? Benzinga16:06 7-May-26

Moderna Reaches Analyst Target Price Nasdaq12:17 7-May-26

Is Wall Street Bullish or Bearish on Moderna Stock? Barchart23:19 6-May-26

Deborah Turbeville and Ikram Abulkadir Explore Fashion and the Body AnOther15:20 4-May-26

The Zacks Analyst Blog Highlights Moderna, Merck and Vertex Pharmaceuticals Zacks08:54 4-May-26

Moderna’s strong vaccine sales outside US far surpass estimates Boston Globe22:11 3-May-26

New energy Special Report; CureVac sues Moderna; landmark Hikma hearing; EU on USTR watchlist; Samsung v ZTE ruling;… IAM11:52 3-May-26

Moderna (MRNA) Loss Of US$2.8b Keeps Bearish Narratives In Focus Simply Wall St03:04 3-May-26

Moderna first-quarter revenue jumps on strong overseas Covid vaccine sales The Economic Times20:21 1-May-26

How Moderna (MRNA) Is Recasting Its Vaccine Platform After EU Approval of Its First Combo Shot Simply Wall St18:59 1-May-26

Moderna Reports Q1 Loss, Stock Jumps on Strong International Sales Zacks17:41 1-May-26

Moderna reports mixed Q1 results as revenue beats estimates but litigation charge weighs on… Proactive Investors (US)16:57 1-May-26

Moderna's Legal Hit Steals Spotlight From Strong Sales Benzinga15:45 1-May-26

Moderna (NASDAQ:MRNA) Beats Expectations in Strong Q1 CY2026, Stock Soars Barchart14:09 1-May-26

Moderna's Q1 revenues rocket, thanks to ex-US sales pharmaphorum13:58 1-May-26

Moderna (MRNA) Reports Q1 Loss, Beats Revenue Estimates Zacks13:47 1-May-26

Moderna beats Q1 estimates and reaffirms full-year guidance Sherwood13:06 1-May-26

Moderna Gears Up to Report Q1 Earnings: Here's What to Expect Zacks14:21 28-Apr-26

Moderna sued by CureVac, continuing covid jab maker’s highly eventful start to 2026 IAM13:48 28-Apr-26

Moderna Hit With Suit Over CureVac COVID Patents Law36023:45 27-Apr-26

CureVac Patent Suit Targets Moderna’s Spikevax Covid-19 Shots Bloomberg Law17:57 27-Apr-26

CureVac files Covid-19 vaccine lawsuit against Moderna Commercial Dispute Resolution17:40 27-Apr-26

Europe—not US—first to authorize Moderna’s combo mRNA flu-COVID vaccine Ars Technica22:21 24-Apr-26

Moderna (MRNA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks16:16 24-Apr-26

In Readiness For The Next Pandemic, Human Trials Begin Of An mRNA Vaccine For Bird Flu IFLScience15:21 24-Apr-26

Moderna Starts Large Avian Influenza Study Despite Earlier HHS Funding Loss Pulmonology Advisor14:27 24-Apr-26

Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing Zacks00:00 23-Apr-26

European Commission Approves MRNA's COVID-19-Influenza Combo Shot Zacks17:23 22-Apr-26

Moderna Starts Large Bird Flu Study Despite Earlier HHS Funding Loss HealthDay16:01 22-Apr-26

Moderna continues bird flu vax study, but limits work in the U.S. STAT12:54 22-Apr-26

Pivotal trial of Moderna's H5N1 bird flu jab gets underway pharmaphorum11:35 22-Apr-26

Moderna launches mRNA bird flu vaccine trial after HHS cancels funding The Washington Post02:23 22-Apr-26

expert reaction to Moderna / NIHR launch of new human vaccine trial: mRNA vaccine candidate against H5N1 bird flu Science Media Centre00:19 22-Apr-26

Got $2,000? These Biotech Stocks Are Worth Considering for Long-Term Growth The Motley Fool21:58 21-Apr-26

Europe Clears First Flu/Covid Combo Shot From Moderna Benzinga19:01 21-Apr-26

GSK, Moderna Both Ordered To Provide More Info In Vax Fight Law36020:54 20-Apr-26

What's Pushing Moderna Stock Higher Today? Benzinga16:54 20-Apr-26

Sanofi touts tolerability of COVID shot Nuvaxovid in head-to-head trial vs. Moderna's mNexspike FiercePharma15:59 20-Apr-26

view more headlines

20 May 16:30

About our Moderna news

Latest news on Moderna, a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.

Moderna

About our Moderna news

Biotech Top Stories

UK Top Stories

World Top Stories